About Vutrisiran sodium
Class: | RNA interference therapeutic
Use: | Treatment of hereditary transthyretin-mediated amyloidosis (hATTR) in adults
Adult dose: | 25 mg administered subcutaneously once every 3 months
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Injection site reactions, nausea, diarrhea, fatigue, headache
Contraindications: | Hypersensitivity to Vutrisiran or any component of the formulation
Storage: | Store in the refrigerator at 2°C to 8°C (36°F
Drug Class
RNA interference therapeutic
Uses & Indications
Treatment of hereditary transthyretin-mediated amyloidosis (hATTR) in adults
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; may be stored at room temperature (up to 25°C or 77°F) for up to 30 days
Manufacturer & Packaging
Manufacturer: Alnylam Netherlands B.V[Amsterdam; Netherlands], Netherlands
Package Size
1's Prefilled syringe [0.5ml]
Price & Supplier
Price in UAE: AED 534023.00
Dosage Information
Adult Dose
25 mg administered subcutaneously once every 3 months
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Injection site reactions, nausea, diarrhea, fatigue, headache
Contraindications & Precautions
Hypersensitivity to Vutrisiran or any component of the formulation
Important Warnings
Risk of hypersensitivity reactions; monitor for signs of anaphylaxis; not recommended for use in patients with severe hepatic impairment
Related Medicines in Same Category
See also: Other RNA interference therapeutic medicines available in UAE pharmacies
Givosiran
Lumasiran Sodium
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.